Showing results (431-440 of 527) with videos related to
Sort By:
Pageof 53
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 13, 2012
Interferon (alpha, beta and omega) receptor 2 is a prognostic biomarker for lung cancerSonosuke Tanaka, Noboru Hattori, Nobuhisa Ishikawa, et al.Cancer Science|September 17, 2013
Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibitionKenji Sakogawa, Yoshiro Aoki, Keizo Misumi, et al.BMC Medical Genetics|August 20, 2017
Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targetsYasushi Horimasu, Nobuhisa Ishikawa, Masaya Taniwaki, et al.Journal of Cellular and Molecular Medicine|February 9, 2019
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblastsTakeshi Masuda, Taku Nakashima, Masashi Namba, et al.Clinical Lung Cancer|October 25, 2021
Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303Masayuki Nakao, Hisashi Saji, Mingoyn Mun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2021
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLEAkito Hata, Isamu Okamoto, Naoki Inui, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancerYoshinori Yamashita, Kazuhiko Kataoka, Teruyoshi Ishida, et al.Annals of Surgical Oncology|April 26, 2021
Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303Takahiro Mimae, Hisashi Saji, Hiroshige Nakamura, et al.Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|June 25, 2011
[Archives of "comprehensive approach on asbestos-related diseases" supported by the "special coordination funds for promoting science and technology (H18-1-3-3-1)"-- overview of group research project, care and specimen registration, cellular characteristics of mesothelioma and immunological effects of asbestos]Takemi Otsuki, Takashi Nakano, Seiki Hasegawa, et al.JTO Clinical and Research Reports|April 9, 2026
Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With <i>EGFR</i> Mutation (West Japan Oncology Group 11719L: ADJUST Study)Ryota Shibaki, Hiroaki Akamatsu, Morihito Okada, et al.Pageof 53